Dr. Pan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Elm and Carlton Streets
Buffalo, NY 14263Phone+1 716-845-3221
Summary
- Dr. Dorothy Pan is an oncologist in Buffalo, NY. She received her medical degree from Weill Cornell Medicine and has been in practice 25 years. She specializes in hematologic oncology.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1998 - 2001
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1995 - 1998
Weill Cornell MedicineClass of 1995
Massachusetts Institute of TechnologyB.S., Biology, 1987 - 1991
Certifications & Licensure
NY State Medical License 1997 - 2026- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS Lymphoma Start of enrollment: 2021 May 24
- Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma Start of enrollment: 2021 May 20
- Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma Start of enrollment: 2011 Apr 08
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsOutcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow...Hemant S Murthy, Kwang Woo Ahn, Noel Estrada-Merly, Hassan B Alkhateeb, Susan Bal
Transplantation and Cellular Therapy. 2022-04-01 - 864 citationsCetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by ImmunohistochemistryKi Y. Chung, Jinru Shia, Nancy E. Kemeny, Manish A. Shah, Gary K. Schwartz
Journal of Clinical Oncology. 2005-03-20 - 10 citationsCHOP with high dose cyclophosphamide consolidation versus CHOP alone as initial therapy for advanced stage, indolent non-Hodgkin's lymphomas.Dorothy Pan, Jing Qin, Charles M. Farber, James P. O'Brien, Daniel A. Filippa
Leukemia & Lymphoma. 2003-06-01
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
